source
- NIH grant success rates hit historic low, pushing researchers to seek alternative fundingNIH grant success rates have fallen to historic lows, with only about 13% of applications receiving funding in the most recent fiscal year. Researchers are responding by dedicating more time to wr…
- Avalyn Pharma raises $300M in IPO to fund inhalable lung-fibrosis drugsAvalyn Pharma completed a $300 million initial public offering, pricing 16.7 million shares at $18 each and exceeding its original $200 million target. The proceeds will be used to develop inhalab…